Comparison

MDL 105519 European Partner

Item no. HY-15085-100mg
Manufacturer MedChem Express
CASRN 161230-88-2
Amount 100 mg
Category
Type Inhibitors
Specific against other
Purity 99.00
Formula C18H11Cl2NO4
Citations [1]Baron BM, et al. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. Eur J Pharmacol. 1997 Apr 4;323(2-3):181-92.
Smiles O=C(O)C(N1)=C(/C=C(C2=CC=CC=C2)/C(O)=O)C3=C1C=C(Cl)C=C3Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
MDL 105519 is a potent and selective antagonist of glycine binding to the NMDA receptor.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Neuroscience-Neurodegeneration
MolecularWeight
376.19
Clinical_Information
No Development Reported
Manufacturers Research_Area
Neurological Disease
Solubility
DMSO : 17 mg/mL (ultrasonic; warming)
Manufacturers Target
iGluR
Isoform
NMDA Receptor
Pathway
Membrane Transporter/Ion Channel; Neuronal Signaling
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close